Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Fox

Showing results (41-50 of 141) with videos related to

Pageof 15
Sort By:
Nanoscale|January 14, 2020
Physicochemical structure of a polyacrylic acid stabilized nanoparticle alum (nanoalum) adjuvant governs TH1 differentiation of CD4+ T cellsAmit P Khandhar, Hong Liang, Adrian C Simpson, et al.
International Journal of Pharmaceutics|March 12, 2025
Scale-up of a low-temperature spray-drying process for a tuberculosis vaccine candidate using lab-scale equipmentMaximilian Aisenstat, Joseph McCollum, Mani Ordoubadi, et al.
Pharmaceutical Development and Technology|June 17, 2010
Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsionsChristopher B Fox, Susan Lin, Sandra J Sivananthan, et al.
International Journal of Nanomedicine|March 21, 2014
Cryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomesChristopher B Fox, Sean K Mulligan, Joyce Sung, et al.
Molecular Pharmaceutics|March 19, 2025
Lyophilization Strategy Enhances the Thermostability and Field-Based Stability of Conjugated and Comixed Subunit Liposomal Adjuvant-containing Tuberculosis Vaccine Formulation (ID93 + GLA-LSQ)Babatunde Ayodeji Adeagbo, Morayo Alao, Ochuko Orherhe, et al.
Therapeutic Advances in Vaccines|May 19, 2017
Accounting for adjuvant-induced artifacts in the characterization of vaccine formulations by polyacrylamide gel electrophoresisVirginie Jakob, Livia Brunner, Christophe Barnier-Quer, et al.
Plos One|January 10, 2014
A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93Mark T Orr, Elyse A Beebe, Thomas E Hudson, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 6, 2009
Self-assembly of a triangle-shaped, hexaplatinum-incorporated, supramolecular amphiphile in solution and at interfacesUmamageswaran Maran, David Britt, Christopher B Fox, et al.
ACS Omega|December 16, 2020
Controlled Covalent Conjugation of a Tuberculosis Subunit Antigen (ID93) to Liposome Improved <i>In Vitro</i> Th1-Type Cytokine Recall Responses in Human Whole BloodBabatunde Ayodeji Adeagbo, Akintunde Oluseto Akinlalu, Tony Phan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2018
Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune ResponsesEmilie Seydoux, Hong Liang, Natasha Dubois Cauwelaert, et al.
Pageof 15

Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
Nanoscale|January 14, 2020
Physicochemical structure of a polyacrylic acid stabilized nanoparticle alum (nanoalum) adjuvant governs TH1 differentiation of CD4+ T cellsAmit P Khandhar, Hong Liang, Adrian C Simpson, et al.
International Journal of Pharmaceutics|March 12, 2025
Scale-up of a low-temperature spray-drying process for a tuberculosis vaccine candidate using lab-scale equipmentMaximilian Aisenstat, Joseph McCollum, Mani Ordoubadi, et al.
Pharmaceutical Development and Technology|June 17, 2010
Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsionsChristopher B Fox, Susan Lin, Sandra J Sivananthan, et al.
International Journal of Nanomedicine|March 21, 2014
Cryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomesChristopher B Fox, Sean K Mulligan, Joyce Sung, et al.
Molecular Pharmaceutics|March 19, 2025
Lyophilization Strategy Enhances the Thermostability and Field-Based Stability of Conjugated and Comixed Subunit Liposomal Adjuvant-containing Tuberculosis Vaccine Formulation (ID93 + GLA-LSQ)Babatunde Ayodeji Adeagbo, Morayo Alao, Ochuko Orherhe, et al.
Therapeutic Advances in Vaccines|May 19, 2017
Accounting for adjuvant-induced artifacts in the characterization of vaccine formulations by polyacrylamide gel electrophoresisVirginie Jakob, Livia Brunner, Christophe Barnier-Quer, et al.
Plos One|January 10, 2014
A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93Mark T Orr, Elyse A Beebe, Thomas E Hudson, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 6, 2009
Self-assembly of a triangle-shaped, hexaplatinum-incorporated, supramolecular amphiphile in solution and at interfacesUmamageswaran Maran, David Britt, Christopher B Fox, et al.
ACS Omega|December 16, 2020
Controlled Covalent Conjugation of a Tuberculosis Subunit Antigen (ID93) to Liposome Improved <i>In Vitro</i> Th1-Type Cytokine Recall Responses in Human Whole BloodBabatunde Ayodeji Adeagbo, Akintunde Oluseto Akinlalu, Tony Phan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2018
Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune ResponsesEmilie Seydoux, Hong Liang, Natasha Dubois Cauwelaert, et al.
Pageof 15